Establishing a complete diagnosis offers patients more information about their IRD.1
*Test should be requested through referral to the appropriate centre if not available.
†in younger patients, the fundus may appear normal.
Royal College of Ophthalmologists Guidance on Genomic Services4:
In line with the drive towards a Genomic Medicine Service, it is important that testing is offered to anyone who is eligible and would benefit.
Each examination must include a genetic diagnosis to avoid delays in decision-making.
There are >270 genes associated with an IRD4,5
A genetic test reﬁnes and completes their diagnosis.1
Patients want genetic insight into their disease.6
A genetic test = knowing more.
Treatment options such as gene therapy
need a genetic diagnosis.7,8
A genetic test with segregation analysis.1,9
- Screening of parents or relatives to determine mode of inheritance, i.e. biallelic mutations.1
- This test can be ordered by any physician with a suspected IRD patient or consider referring your patient to a specialist who can perform or order a test.
At the foundation of an accurate IRD diagnosis is a genetic test
The following case studies highlight the important role genetic testing plays to achieve a final diagnosis.
Reduced VA, colour defects, nystagmus and reduced ERG are common across a range of IRDs including achromatopsia, Leber congenital amaurosis and retinitis pigmentosa.
Without a genetic test the patient cannot receive a definitive and complete diagnosis.3
Three centres in the UK provide all genetic testing within ophthalmology4:
London North GLH led by Great Ormond Street Hospital for Children NHS Foundation Trust
North West GLH led by Manchester University NHS Foundation Trust
West Midlands, Oxford and Wessex GLH
The Genomic Test Directory defines a series of clinical indications for which genomic tests are available including inherited retinal disorders (retinal dystrophies and vitreoretinal disorders).
Centralised funding from NHS England means that molecular genetic testing should be both possible and affordable.
The drive towards a national Genomic Medicine Service means that testing is offered to anyone who is eligible and who would benefit.
In the UK, a genetic test* can be ordered from one of the three Genomic Laboratory Hubs. The Hubs will be able to advise on how to request a test for a particular patient, and comprehensive information and instructions can be found on their individual websites.
*Genetic testing should be accompanied by patient consent and full genetic counselling.
Give patients with IRDs the opportunity for a complete diagnosis with a clinical and genetic test.1
ERG, electroretinography; FST, full-field stimulus test; GLH, Genomic Laboratory Hub; IRD, inherited retinal dystrophy; LCA, Leber congenital amaurosis; NHS, National Health Service; OCT, optical coherence tomography; RP, retinitis pigmentosa; VA, visual acuity.
- American Academy of Ophthalmology®, IRD Clinical Statement. 2016. https://www.aao.org/clinical-statementrecommendations-on-clinical-assessment-of-patients (accessed March 2020).
- Chung D et al. Am J Ophthalmol 2019;199:58–70.
- Sahel JA Cold Spring Harb Perspect Biol 2015;5(2):a017111.
- The Royal College of Ophthalmologists Genomic Services Guide February 2020. https://www.rcophth.ac.uk/standards-publications-research/ophthalmic-services-guidance-2/ (accessed July 2020).
- RetNet. https://sph.uth.edu/retnet/ sum-dis.htm#A-genes (accessed March 2020).
- Willis TA et al. Br J Ophthalmol 2013;97(9):1148–1154.
- Russell S et al. The Lancet 2017;390(10097):849–860.
- Voretigene neparvovec Summary of Product Characteristics. Last updated 20.12.2019.
- Moosajee M et al. Eur J Hum Genet 2014;22(4):e1–e4.
- Di Ioro V et al. Genes 2017;8:280–297.
- Pieh C et al. Br J Ophthalmol 2008;92:236–240.